14.63
price up icon1.67%   0.24
after-market Dopo l'orario di chiusura: 14.74 0.11 +0.75%
loading
Precedente Chiudi:
$14.39
Aprire:
$14.18
Volume 24 ore:
574.60K
Relative Volume:
0.64
Capitalizzazione di mercato:
$1.54B
Reddito:
-
Utile/perdita netta:
$-115.88M
Rapporto P/E:
-9.4582
EPS:
-1.5468
Flusso di cassa netto:
$-104.72M
1 W Prestazione:
+6.55%
1M Prestazione:
-0.81%
6M Prestazione:
-48.30%
1 anno Prestazione:
-30.93%
Intervallo 1D:
Value
$14.01
$14.66
Intervallo di 1 settimana:
Value
$13.34
$14.66
Portata 52W:
Value
$10.60
$38.12

Edgewise Therapeutics Inc Stock (EWTX) Company Profile

Name
Nome
Edgewise Therapeutics Inc
Name
Telefono
720-262-7002
Name
Indirizzo
1715 38TH ST, BOULDER
Name
Dipendente
117
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-03
Name
Ultimi documenti SEC
Name
EWTX's Discussions on Twitter

Confronta EWTX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
EWTX
Edgewise Therapeutics Inc
14.63 1.51B 0 -115.88M -104.72M -1.5468
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-30 Iniziato H.C. Wainwright Buy
2025-04-30 Iniziato Guggenheim Buy
2025-04-02 Downgrade Scotiabank Sector Outperform → Sector Perform
2025-03-07 Iniziato Scotiabank Sector Outperform
2025-01-22 Iniziato Stifel Hold
2024-11-22 Iniziato Evercore ISI Outperform
2024-03-07 Iniziato Piper Sandler Overweight
2023-05-01 Iniziato Truist Buy
2022-08-25 Downgrade Goldman Neutral → Sell
2022-04-13 Iniziato RBC Capital Mkts Outperform
2022-01-28 Iniziato Goldman Neutral
Mostra tutto

Edgewise Therapeutics Inc Borsa (EWTX) Ultime notizie

pulisher
Jul 24, 2025

What analysts say about Edgewise Therapeutics Inc. stockOutstanding capital growth - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Edgewise Therapeutics, Inc. (EWTX) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Jul 24, 2025
pulisher
Jul 24, 2025

What drives Edgewise Therapeutics Inc. stock priceFast-track wealth growth - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Edgewise Therapeutics Inc. Stock Analysis and ForecastMarket-leading growth rates - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Becker Muscular Dystrophy Pipeline 2025: Key Companies, MOA, - openPR.com

Jul 24, 2025
pulisher
Jul 23, 2025

BlackRock, Inc. Reduces Stake in Edgewise Therapeutics Inc. - GuruFocus

Jul 23, 2025
pulisher
Jul 23, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Purchased by Arizona State Retirement System - Defense World

Jul 23, 2025
pulisher
Jul 23, 2025

Is Edgewise Therapeutics Inc. a good long term investmentConsistently superior profits - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Edgewise Therapeutics, Inc. (EWTX) And Encourages Investors to Reach Out - ACCESS Newswire

Jul 22, 2025
pulisher
Jul 22, 2025

Readystate Asset Management LP Boosts Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc.EWTX - MarketScreener

Jul 22, 2025
pulisher
Jul 22, 2025

Jennison Associates LLC Purchases New Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Jul 22, 2025
pulisher
Jul 21, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Edgewise Therapeutics, Inc. (EWTX) And Encourages Stockholders to Reach Out - ACCESS Newswire

Jul 21, 2025
pulisher
Jul 19, 2025

EWTX Investors Have Opportunity to Join Edgewise Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - The Globe and Mail

Jul 19, 2025
pulisher
Jul 18, 2025

When is the best time to buy Edgewise Therapeutics Inc. stockSmart Growth Low Risk Picks - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc.EWTX - cnhinews.com

Jul 17, 2025
pulisher
Jul 16, 2025

why edgewise therapeutics inc. stock attracts strong analyst attentionFree Professional Portfolio Management - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Edgewise Therapeutics Inc. stock price move sharplyQuick Profit Idea Stream - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Edgewise Therapeutics Inc. stock performs during market volatilityShort Squeeze Radar - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Edgewise Therapeutics Inc. stock attracts strong analyst attentionSmart Money Signals - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Stock Price Up 7.9%Time to Buy? - MarketBeat

Jul 12, 2025
pulisher
Jul 08, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Jul 08, 2025
pulisher
Jul 07, 2025

Edgewise Therapeutics Reports Positive Results for Muscular Dystrophy Treatment - MSN

Jul 07, 2025
pulisher
Jul 05, 2025

(EWTX) Trading Report - news.stocktradersdaily.com

Jul 05, 2025
pulisher
Jul 03, 2025

User - FinancialContent

Jul 03, 2025
pulisher
Jun 30, 2025

HC Wainwright Initiates Edgewise Therapeutics With Buy Rating, $42 Price Target - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Edgewise Therapeutics (EWTX) Initiated with Buy Rating by HC Wainwright | EWTX Stock News - GuruFocus

Jun 30, 2025
pulisher
Jun 29, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap DownHere's Why - MarketBeat

Jun 29, 2025
pulisher
Jun 28, 2025

Analysts Offer Insights on Healthcare Companies: BeiGene (ONC), Vertex Pharmaceuticals (VRTX) and Edgewise Therapeutics (EWTX) - The Globe and Mail

Jun 28, 2025
pulisher
Jun 27, 2025

Edgewise Therapeutics (EWTX) Advances Sevasemten Trials in Muscu - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

Edgewise Therapeutics Shares Drop After FDA Withholds Accelerated Approval for Muscle Disorder Drug - MSN

Jun 27, 2025
pulisher
Jun 26, 2025

Edgewise Therapeutics Reports Positive Results on Sevasemten Program for Becker and Duchenne Muscular Dystrophies - WV News

Jun 26, 2025

Edgewise Therapeutics Inc Azioni (EWTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):